Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-14

Clinical Trial Update: Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients. [NA]

View source ↗

Summary

Clinical trial update examining the necessity of TSH suppression therapy in active surveillance for thyroid cancer, including papillary thyroid carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Thyroid Cancer, Papillary Thyroid Carcinoma | NA | Status: NOT_YET_RECRUITING